Insider Transactions in Q3 2021 at Hcw Biologics Inc. (HCWB)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 15
2021
|
Medmira Capital Ltd. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
3,587,659
-100.0%
|
-
|
|
Aug 31
2021
|
Hing C Wong Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
3,830
+0.03%
|
$11,490
$3.93 P/Share
|
|
Aug 30
2021
|
Hing C Wong Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
6,000
+0.04%
|
$18,000
$3.93 P/Share
|
|
Aug 27
2021
|
Hing C Wong Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
6,000
+0.04%
|
$18,000
$3.77 P/Share
|
|
Aug 26
2021
|
Hing C Wong Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
6,500
+0.04%
|
$19,500
$3.84 P/Share
|
|
Aug 25
2021
|
Rick S. Greene |
BUY
Open market or private purchase
|
Direct |
3,611
+50.0%
|
$14,444
$4.1 P/Share
|
|
Aug 23
2021
|
Lee Flowers SVP of Business Development |
BUY
Open market or private purchase
|
Direct |
5,605
+5.76%
|
$16,815
$3.95 P/Share
|
|
Aug 20
2021
|
Lee Flowers SVP of Business Development |
BUY
Open market or private purchase
|
Direct |
7,853
+8.36%
|
$31,412
$4.08 P/Share
|
|
Aug 19
2021
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+13.89%
|
$40,000
$4.4 P/Share
|
|
Aug 19
2021
|
Lee Flowers SVP of Business Development |
BUY
Open market or private purchase
|
Direct |
10,532
+11.87%
|
$42,128
$4.25 P/Share
|
|
Jul 22
2021
|
Hing C Wong Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
627,500
+3.95%
|
$5,020,000
$8.0 P/Share
|
|
Jul 22
2021
|
Hing C Wong Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
10,342,404
+20.68%
|
-
|
|
Jul 22
2021
|
Rebecca Byam Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
25,000
+32.47%
|
$200,000
$8.0 P/Share
|
|
Jul 22
2021
|
Lee Flowers SVP of Business Development |
BUY
Open market or private purchase
|
Direct |
31,250
+31.59%
|
$250,000
$8.0 P/Share
|
|
Jul 22
2021
|
Peter Rhode Officer |
BUY
Open market or private purchase
|
Direct |
12,500
+21.08%
|
$100,000
$8.0 P/Share
|
|
Jul 22
2021
|
Scott T Garrett |
BUY
Open market or private purchase
|
Indirect |
125,000
+50.0%
|
$1,000,000
$8.0 P/Share
|
|
Jul 22
2021
|
Medmira Capital Ltd. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
3,587,661
+33.46%
|
-
|